Supplementary Tables 1-9 from Pathology of Breast and Ovarian Cancers among &lt;i&gt;BRCA1&lt;/i&gt; and &lt;i&gt;BRCA2&lt;/i&gt; Mutation Carriers: Results from the Consortium of Investigators of Modifiers of &lt;i&gt;BRCA1&lt;/i&gt;/&lt;i&gt;2&lt;/i&gt; (CIMBA)